MAPK14 and cancer: Our study found that CLEFMA induced the heme oxygenase-1 (HO-1) level by activating p38 mitogen-activated protein kinase signalling cascade and subsequently activated caspase-dependent cell death, which is critical to the anti-cancer effect in OSCC.